• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception.接受激素避孕的未感染艾滋病毒女性体内的CCR5表达水平。
J Infect Dis. 2015 Nov 1;212(9):1397-401. doi: 10.1093/infdis/jiv233. Epub 2015 Apr 20.
2
Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.三种长效可逆避孕方法对人宫颈和外周血中 HIV 靶细胞的影响。
Reprod Biol Endocrinol. 2019 Feb 22;17(1):26. doi: 10.1186/s12958-019-0469-8.
3
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.肌肉注射长效醋酸甲羟孕酮、含铜宫内节育器或左炔诺孕酮皮下埋植避孕的女性中的艾滋病毒感染发病率:一项随机、多中心、开放性标签试验。
Lancet. 2019 Jul 27;394(10195):303-313. doi: 10.1016/S0140-6736(19)31288-7. Epub 2019 Jun 13.
4
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.醋酸甲羟孕酮长效注射剂、宫内节育器含铜宫内节育器和左炔诺孕酮植入剂对早期HIV疾病进展的影响。
AIDS Res Hum Retroviruses. 2020 Aug;36(8):632-640. doi: 10.1089/AID.2020.0015. Epub 2020 Jun 2.
5
Increased Cervical CD4CCR5 T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate.使用醋酸甲羟孕酮的肯尼亚性工作女性中宫颈CD4CCR5 T细胞增加。
AIDS Res Hum Retroviruses. 2019 Mar;35(3):236-246. doi: 10.1089/AID.2018.0188. Epub 2019 Jan 24.
6
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.人工流产后避孕选择左炔诺孕酮宫内节育器、依托孕烯植入剂或醋酸甲羟孕酮长效避孕针。
Contraception. 2015 Dec;92(6):553-9. doi: 10.1016/j.contraception.2015.06.013. Epub 2015 Jun 17.
7
Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.1型人类免疫缺陷病毒感染对婴幼儿及青少年CD4 T淋巴细胞亚群中CCR5和CXCR4共受体表达的影响。
AIDS Res Hum Retroviruses. 2004 Mar;20(3):305-13. doi: 10.1089/088922204322996545.
8
Changes in genital tract immune cell populations after initiation of intrauterine contraception.宫内节育器放置后生殖道免疫细胞群体的变化。
Am J Obstet Gynecol. 2014 Nov;211(5):489.e1-9. doi: 10.1016/j.ajog.2014.05.016. Epub 2014 May 13.
9
Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.醋酸甲羟孕酮长效注射剂、左炔诺孕酮宫内节育系统及铜宫内节育器使用者长达十年的体重变化。
Eur J Contracept Reprod Health Care. 2015 Feb;20(1):57-63. doi: 10.3109/13625187.2014.951433. Epub 2014 Aug 27.
10
Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women.探索醋酸甲羟孕酮长效注射剂和内源性孕酮水平在感染和未感染HIV的女性中的免疫调节作用。
BMC Res Notes. 2019 Nov 15;12(1):745. doi: 10.1186/s13104-019-4785-z.

引用本文的文献

1
Injectable Contraceptives Differentially Affect Select CD4+ HIV-1 Target Cells in the Genital Tract but Not Systemically: Implications for HIV-1 Acquisition.注射用避孕药对生殖道中特定的CD4+ HIV-1靶细胞有不同影响,但对全身无此影响:对HIV-1感染的意义。
Am J Reprod Immunol. 2025 May;93(5):e70093. doi: 10.1111/aji.70093.
2
Female Sex Hormones Upregulate the Replication Activity of HIV-1 Sub-Subtype A6 and CRF02_AG but Not HIV-1 Subtype B.女性性激素上调HIV-1 A6亚亚型和CRF02_AG的复制活性,但不上调HIV-1 B亚型的复制活性。
Pathogens. 2023 Jun 27;12(7):880. doi: 10.3390/pathogens12070880.
3
Distinct mucosal and systemic immunological characteristics in transgender women potentially relating to HIV acquisition.跨性别女性具有独特的黏膜和全身免疫特征,可能与 HIV 的获得有关。
JCI Insight. 2023 Aug 22;8(16):e169272. doi: 10.1172/jci.insight.169272.
4
Multiancestry sex-stratified genomic associations with HIV viral load and controller status from the ICGH.国际 HIV 基因组合作组织开展的多祖先性别分层遗传关联与 HIV 病毒载量和控制者状态研究。
JCI Insight. 2023 Jun 8;8(11):e170068. doi: 10.1172/jci.insight.170068.
5
Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms.体外用人月经周期激素或甲羟孕酮处理的 PBMCs 中 HIV-1 感染增加可能通过不同的机制发生。
Am J Reprod Immunol. 2022 Dec;88(6):e13643. doi: 10.1111/aji.13643. Epub 2022 Nov 2.
6
People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells.HIV 感染者循环中 CCR5+ CD8+ T 细胞的比例较高,而 CCR5+ 调节性 T 细胞的比例较低。
Sci Rep. 2022 Jul 6;12(1):11425. doi: 10.1038/s41598-022-15646-0.
7
An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract.关于 depot 甲羟孕酮对女性生殖道黏膜生物学影响的更新综述。
Am J Reprod Immunol. 2021 Sep;86(3):e13455. doi: 10.1111/aji.13455. Epub 2021 Jun 12.
8
Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.Zim CHIC:一项关于女性生殖道与避孕起始和使用相关的免疫变化的队列研究。
Am J Reprod Immunol. 2020 Sep;84(3):e13287. doi: 10.1111/aji.13287. Epub 2020 Jun 25.
9
Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women.探索醋酸甲羟孕酮长效注射剂和内源性孕酮水平在感染和未感染HIV的女性中的免疫调节作用。
BMC Res Notes. 2019 Nov 15;12(1):745. doi: 10.1186/s13104-019-4785-z.
10
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.避孕药醋酸甲羟孕酮与诺孕酯不同,它能在生理相关浓度下直接增加人体宫颈组织中 R5 HIV-1 的感染。
Sci Rep. 2019 Mar 13;9(1):4334. doi: 10.1038/s41598-019-40756-7.

本文引用的文献

1
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.激素避孕与感染艾滋病毒的风险:一项个体参与者数据荟萃分析。
PLoS Med. 2015 Jan 22;12(1):e1001778. doi: 10.1371/journal.pmed.1001778. eCollection 2015 Jan.
2
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.激素避孕方法的使用与女性获得 HIV 的风险:观察性研究的荟萃分析。
Lancet Infect Dis. 2015 Feb;15(2):181-9. doi: 10.1016/S1473-3099(14)71052-7. Epub 2015 Jan 9.
3
Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.使用左炔诺孕酮宫内缓释系统的患者中左炔诺孕酮血药浓度的定量测定:规律使用和延长使用。
Contraception. 2012 Oct;86(4):345-9. doi: 10.1016/j.contraception.2012.01.015. Epub 2012 Mar 6.
4
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.激素避孕与 HIV-1 传播风险:一项前瞻性队列研究。
Lancet Infect Dis. 2012 Jan;12(1):19-26. doi: 10.1016/S1473-3099(11)70247-X. Epub 2011 Oct 3.
5
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.在接受抑制性抗逆转录病毒治疗的 HIV 阳性患者的肠道内,HIV 负担和免疫激活存在差异。
J Infect Dis. 2010 Nov 15;202(10):1553-61. doi: 10.1086/656722. Epub 2010 Oct 12.
6
A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.一种定量亲和分析系统,可揭示人类免疫缺陷病毒1型和猿猴免疫缺陷病毒毒株之间不同的CD4/CCR5使用模式。
J Virol. 2009 Nov;83(21):11016-26. doi: 10.1128/JVI.01242-09. Epub 2009 Aug 19.
7
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.HIV储存库的大小和持久性由T细胞存活和稳态增殖驱动。
Nat Med. 2009 Aug;15(8):893-900. doi: 10.1038/nm.1972. Epub 2009 Jun 21.
8
Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内缓释系统长期使用期间的血清左炔诺孕酮水平及子宫内膜厚度
Contraception. 2009 Jul;80(1):84-9. doi: 10.1016/j.contraception.2009.01.004. Epub 2009 Feb 27.
9
The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.女性跨机构HIV研究:一项观察性队列研究将临床科学引入实验室。
Clin Diagn Lab Immunol. 2005 Sep;12(9):1013-9. doi: 10.1128/CDLI.12.9.1013-1019.2005.
10
Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.两种不同的野生型1型人类免疫缺陷病毒分离株在适应性上的差异与细胞结合和进入的效率有关。
J Virol. 2005 Jun;79(11):7121-34. doi: 10.1128/JVI.79.11.7121-7134.2005.

接受激素避孕的未感染艾滋病毒女性体内的CCR5表达水平。

CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception.

作者信息

Sciaranghella Gaia, Wang Cuiwei, Hu Haihong, Anastos Kathryn, Merhi Zaher, Nowicki Marek, Stanczyk Frank Z, Greenblatt Ruth M, Cohen Mardge, Golub Elizabeth T, Watts D Heather, Alter Galit, Young Mary A, Tsibris Athe M N

机构信息

Ragon Institute of MGH, MIT, and Harvard, Boston, Massachusetts.

Georgetown University Medical Center, Washington D.C.

出版信息

J Infect Dis. 2015 Nov 1;212(9):1397-401. doi: 10.1093/infdis/jiv233. Epub 2015 Apr 20.

DOI:10.1093/infdis/jiv233
PMID:25895986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4601918/
Abstract

Human immunodeficiency virus (HIV) infectivity increases as receptor/coreceptor expression levels increase. We determined peripheral CD4, CCR5, and CXCR4 expression levels in HIV-uninfected women who used depot medroxyprogesterone acetate (DMPA; n = 32), the levonorgestrel-releasing intrauterine device (LNG-IUD; n = 27), oral contraceptive pills (n = 32), or no hormonal contraception (n = 33). The use of LNG-IUD increased the proportion of CD4(+) and CD8(+) T cells that expressed CCR5; increases in the magnitude of T-cell subset CCR5 expression were observed with DMPA and LNG-IUD use (P < .01 for all comparisons). LNG-IUD and, to a lesser extent, DMPA use were associated with increased peripheral T-cell CCR5 expression.

摘要

随着受体/共受体表达水平的升高,人类免疫缺陷病毒(HIV)的感染性增强。我们测定了未感染HIV的女性外周血中CD4、CCR5和CXCR4的表达水平,这些女性分别使用了醋酸甲羟孕酮长效避孕针(DMPA;n = 32)、左炔诺孕酮宫内节育器(LNG-IUD;n = 27)、口服避孕药(n = 32)或未采取激素避孕措施(n = 33)。使用LNG-IUD增加了表达CCR5的CD4(+)和CD8(+) T细胞的比例;使用DMPA和LNG-IUD后,T细胞亚群CCR5表达量增加(所有比较的P < .01)。使用LNG-IUD以及在较小程度上使用DMPA与外周血T细胞CCR5表达增加有关。